Companion Animal Vaccines Market: Advanced R&D Process Strategies

Posted by Ganesh Shinde on December 22nd, 2022

The remarkable increase in companion animal ownership, combined with the rapid development of veterinary healthcare infrastructure, drives the global market for companion animal vaccines.

The global Companion Animal Vaccines Market is expected to exceed US$ 2.5 billion in revenue in 2021, with a robust CAGR between 2022 and 2029.

The measurable rise in zoonotic disease prevalence will continue to fuel demand for companion animal vaccines and drugs.

FDA approvals for novel and innovative companion animal vaccines continue to present potential growth opportunities for companion animal vaccine research and development.

For example, Zoetis received regulatory approval for ProHeart, which is used to prevent heartworm disease in dogs caused by Dirofilaria immitis.

Increasing R&D Investments to Widen Market Growth Prospects

Elanco, Ceva Sante Animale, Boehringer Ingelheim are among the leading market players in the companion animal vaccines market.

These manufacturers continue to dominate the market landscape of companion animal vaccines by investing heavily in R&D activities to develop and launch therapeutic vaccines for prevention and treatment of various animal diseases.

Surge in investment for R&D of vaccines, which inhibit the growth of antibiotic-resistant organisms boosts the animal vaccines market growth.

For instance, in August 2018, Elanco invested two-thirds of the budget for food‐animal unit to develop vaccines and reduce the use of antibiotics.

Moreover, rise in demand for animal vaccines led to the development of multiple new vaccines.

For instance, Cevac IBron a new vaccine was launched by Ceva in February 2017 for prevention against infectious bronchitis virus (IBV) in animals.

Know More About Companion Animal Vaccines Market Report

Future Market Insight brings the comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2029.

The global companion animal vaccines is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. 

The study provides compelling insights of the companion animal vaccines market on basis of product type (attenuated live vaccines, conjugated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, recombinant vaccines), species type (canine, avian, feline) and distribution channel (companion animal hospitals, companion animal hospitals, companion animal research institutes) across seven major regions.

Segmented 

Product

• Attenuated Live Vaccines
• Conjugate Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• DNA Vaccines
• Recombinant Vaccines

Species

• Canine
• Avian
• Feline

Distribution Channel

• Veterinary Clinics
• Veterinary Hospitals
• Veterinary Research Institutes
• Retail Pharmacies

Browse More Details@ https://www.futuremarketinsights.com/reports/companion-animal-vaccines-market